Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The syndrome of apparent mineralocorticoid excess (AME) is an inherited form of human hypertension thought to result from a deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme normally converts cortisol to inactive cortisone and is postulated to thus confer specificity for aldosterone upon the mineralocorticoid receptor. We have analysed the gene encoding the kidney isozyme of 11 beta HSD and found mutations on both alleles in nine of 11 AME patients (eight of nine kindreds). These mutations markedly affect enzymatic activity. They thus permit cortisol to occupy the renal mineralocorticoid receptor and thereby cause sodium retention and hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [588]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Ulick, S., Milora, R. V., Findling, J. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90250-x · Cited by 1,259
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Research works printed but not linked: 3
- Werder, E., Zachmann, M., Völlmin, J.A., Veyrat, R. & Prader, A. Unusual steroid excretion in a child with low renin hypertension. Res. Steroids 6, 385–389 (1974).
- Winter, J.S.D. & McKenzie, J.K. (1977). A syndrome of low-renin hypertension in children. In Juvenile Hypertension (eds New, M.I. & Levin, L.S.) 123–133 (Raven Press, New York, 1977).
- Higuchi, R. Recombinant PCR. In PCR Protocols (eds Innis, M.A., Gelfand, D.H., Sninsky, J.J. & White, T.J.) 177–183 (Academic, San Diego,1990).
Cited by
Items 101–200 of 664
Apparent cortisone reductase deficiency: a unique form of hypercortisolism
Phillipov, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3855 · Cited by 83
A Genome-Wide Search For Susceptibility Loci to Human Essential Hypertension
Sharma, P., Fatibene, J., Ferraro, F., Jia, H., Monteith, S., Brown, C. C., Clayton, D. G., O’Shaughnessy, K. M., & Brown, M. J. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1291 · Cited by 95
Finken, M. J. J., Andrews, R. C., Andrew, R., & Walker, B. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6009 · Cited by 88
Sodium Intake and Vascular Stiffness in Hypertension
Safar, M. E., Temmar, M., Kakou, A., Lacolley, P., & Thornton, S. N. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129585 · Cited by 83
Apparent mineralocorticoid excess syndrome: an overview
Palermo, M., Quinkler, M., & Stewart, P. M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500015 · Cited by 92
Melander, O., Orho‐Melander, M., Bengtsson, K., Lindblad, U., Råstam, L., Groop, L., & Hulthén, U. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.389 · Cited by 92
Inherited Forms of Mineralocorticoid Hypertension
White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.927 · Cited by 92
Self-citationMonogenic low renin hypertension
New, M. I., Geller, D. S., Fallo, F., & Wilson, R. C. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.011 · Cited by 91
Apparent Mineralocorticoid Excess: Genotype Is Correlated With Biochemical Phenotype
Mune, T., & White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1193 · Cited by 86
Self-citationRicketts, M., Shoesmith, K., Hewison, M., Strain, A., Eggo, M., & Stewart, P. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560159 · Cited by 80
Metabolic conversion as a pre‐receptor control mechanism for lipophilic hormones
Nobel, S., Abrahmsen, L., & Oppermann, U. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02359.x · Cited by 80
The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P., Lovati, E., & Frey, F. J. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018030-00001 · Cited by 90
Non-genomic effect of glucocorticoids on cardiovascular system
Lee, S. R., Kim, H. K., Youm, J. B., Dizon, L. A., Song, I. S., Jeong, S. H., Seo, D. Y., Ko, K. S., Rhee, B. D., Kim, N., et al. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1155-2 · Cited by 90
Ferrari, P. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00053-8 · Cited by 90
Oppermann, U. C. T., & Maser, E. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00744.x · Cited by 90
Shimojo, M., Ricketts, M. L., Petrelli, M. D., Moradi, P., Johnson, G. D., Bradwell, A. R., Hewison, M., Howie, A. J., & Stewart, P. M. (1997) · Endocrinology · doi:10.1210/endo.138.3.4994 · Cited by 80
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 91
Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms
Majid, D. S. A., Prieto, M., & Navar, L. G. (2015) · Current Hypertension Reviews · doi:10.2174/1573402111666150530203858 · Cited by 91
Salt-Sensitive Hypertension and the Kidney
Nishimoto, M., Griffin, K. A., Wynne, B. M., & Fujita, T. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21369 · Cited by 89
Svensson-Färbom, P., Wahlstrand, B., Almgren, P., Dahlberg, J., Fava, C., Kjeldsen, S., Hedner, T., & Melander, O. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283410390 · Cited by 77
Smith, R. E., Li Kevin, X. Z., Andrews, R. K., & Krozowski, Z. (1997) · Endocrinology · doi:10.1210/endo.138.2.4926 · Cited by 79
Seckl, J. R., & Chapman, K. E. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00361.x · Cited by 77
Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor
Chen, S.-Y., Wang, J., Liu, W., & Pearce, D. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c39 · Cited by 87
Sheppard, K. E., & Autelitano, D. J. (2002) · Endocrinology · doi:10.1210/endo.143.1.8583 · Cited by 76
Watson, B., Bergman, S. M., Myracle, A., Callen, D. F., Acton, R. T., & Warnock, D. G. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.478 · Cited by 83
Genetics of hypertension: From experimental animals to humans
Delles, C., McBride, M., Graham, D., Padmanabhan, S., & Dominiczak, A. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.006 · Cited by 86
Rohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 85
Subcellular Localization of the Type 2 11β-Hydroxysteroid Dehydrogenase
Náray-Fejes-Tóth, A., & Fejes-Tóth, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15436 · Cited by 75
Angius, A., Petretto, E. G., Maestrale, G. B., Forabosco, P., Casu, G., Piras, D., Fanciulli, M., Falchi, M., Melis, P. M., Palermo, M., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342929 · Cited by 85
Holmes, M. C., Kotelevtsev, Y. V., Mullins, J. J., & Seckl, J. R. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00386-5 · Cited by 84
Aldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced Hypertension
Quaschning, T., Ruschitzka, F. T., Shaw, S., & Lüscher, T. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.801 · Cited by 84
Yau, M., Haider, S. M., Khattab, A., Ling, C., Mathew, M., Zaidi, S., Bloch, M., Patel, M., Ewert, S., Abdullah, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716621115 · Cited by 83
Melander, O., Orho, M., Fagerudd, J. A., Bengtsson, K., Groop, P., Mattiasson, I., Groop, L., & Hulthén, U. L. (1998) · Hypertension · doi:10.1161/01.hyp.31.5.1118 · Cited by 83
Positive Association of Tyrosine Hydroxylase Microsatellite Marker to Essential Hypertension
Sharma, P., Hingorani, A., Jia, H., Ashby, M., Hopper, R., Clayton, D., & Brown, M. J. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.676 · Cited by 80
Molecular genetics of human hypertension
Gong, M., & Hübner, N. (2006) · Clinical Science · doi:10.1042/cs20050208 · Cited by 82
11β-Hydroxysteroid Dehydrogenase and Its Role in the Syndrome of Apparent Mineralocorticoid Excess
White, P. C. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200112000-00003 · Cited by 82
Self-citationPotassium Transport in the Mammalian Collecting Duct
Muto, S. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.85 · Cited by 80
N'Gankam, V., Uehlinger, D. E., Dick, B., Frey, B. M., & Frey, F. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00308.x · Cited by 80
Schuster, H., Wienker, T. F., Toka, H. R., Bähring, S., Jeschke, E., Toka, O., Busjahn, A., Hempel, A., Tahlhammer, C., Oelkers, W., et al. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.1085 · Cited by 80
Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state
Li, A., Li, K. X. Z., Marui, S., Krozowski, Z. S., Batista, M. C., Whorwood, C. B., Arnhold, I. J. P., Shackleton, C. H. L., Mendonca, B. B., & Stewart, P. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715120-00005 · Cited by 75
Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease
Watson, B., Khan, M. A., Desmond, R. A., & Bergman, S. M. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.26848 · Cited by 79
Herrmann, S.-M., Nicaud, V., Tiret, L., Evans, A., Kee, F., Ruidavets, J., Arveiler, D., Luc, G., Morrison, C. E., Hoehe, M. R., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200202000-00012 · Cited by 79
Martinerie, L., Munier, M., Menuet, D. L., Méduri, G., Viengchareun, S., & Lombès, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.030 · Cited by 78
Genetic linkage of β and γ subunits of epithelial sodium channel to systolic blood pressure
Wong, Z. Y. H., Stebbing, M. S., Ellis, J. A., Lamantia, A., & Harrap, S. B. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10118-6 · Cited by 78
Apparent mineralocorticoid excess: Type I and type II
Mantero, F., Palermo, M., Petrelli, M. D., Tedde, R., Stewart, P. M., & Shackleton, C. H. L. (1996) · Steroids · doi:10.1016/0039-128x(96)00012-8 · Cited by 77
17β-Hydroxysteroid Dehydrogenase Type XI Localizes to Human Steroidogenic Cells
Chai, Z., Brereton, P., Suzuki, T., Sasano, H., Obeyesekere, V., Escher, G., Saffery, R., Fuller, P., Enriquez, C., & Krozowski, Z. (2003) · Endocrinology · doi:10.1210/en.2002-221030 · Cited by 64
Apparent mineralocorticoid excess
Wilson, R. C., Nimkarn, S., & New, M. I. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00356-8 · Cited by 75
LISTER, K., Autelitano, D. J., Jenkins, A. J., Hannan, R. D., & Sheppard, K. E. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.010 · Cited by 75
Immunolocalization of NAD-dependent 11β-hydroxysteroid dehydrogenase in human kidney and colon
Kyossev, Z. N., Walker, P. D., & Reeves, W. B. (1996) · Kidney International · doi:10.1038/ki.1996.39 · Cited by 75
Ionizing radiation and genetic risks
Sankaranarayanan, K., & Chakraborty, R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00106-8 · Cited by 74
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases
Beseda, I., Czollner, L., Shah, P., Khunt, R. C., Gaware, R., Kosma, P., Stanetty, C., Ruiz-Ruiz, M. C. D., Amer, H., Mereiter, K., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.036 · Cited by 73
11β-Hydroxysteroid dehydrogenase: unexpected connections
Walker, E. A., & Stewart, P. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00134-6 · Cited by 72
Crystal Structure of the Mineralocorticoid Receptor DNA Binding Domain in Complex with DNA
Hudson, W. H., Youn, C., & Ortlund, E. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107000 · Cited by 62
Positional identification of variants of Adamts16 linked to inherited hypertension
Joe, B., Saad, Y. M., Lee, N. H., Frank, B. C., Oduaran, O. H., Luu, T. V., Gopalakrishnan, K., Toland, E. J., Farms, P., Yerga‐Woolwine, S., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp218 · Cited by 72
Rogerson, F. M., Kayes, K. M., & White, P. C. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04027-6 · Cited by 72
Self-citationNunez, B. S., Rogerson, F. M., Mune, T., Igarashi, Y., Nakagawa, Y., Phillipov, G., Moudgil, A., Travis, L. B., Palermo, M., Shackleton, C., et al. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.638 · Cited by 68
Self-citationMendelian Forms of Human Hypertension and Mechanisms of Disease
Luft, F. C. (2003) · Clinical Medicine & Research · doi:10.3121/cmr.1.4.291 · Cited by 71
Dahlberg, J., Nilsson, L.-O., von Wowern, F., & Melander, O. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000432 · Cited by 70
Wan, Z., Chenail, E., Xiang, J. S., Li, H., Ipek, M., Bard, J., Svenson, K., Mansour, T. S., Xu, X., Tian, X., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900639u · Cited by 69
Thiel, B., Chakravarti, A., Cooper, R., Luke, A. H., Lewis, S., Lynn, A., Tiwari, H. K., Schork, N. J., & Weder, A. B. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03246-6 · Cited by 69
Hult, M., Jörnvall, H., & Oppermann, U. C. T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01515-4 · Cited by 60
Oppermann, U. C. T., Persson, B., & Jörnvall, H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00355.x · Cited by 66
Brand, E., Kato, N., Chatelain, N., Krozowski, Z. S., Jeunemaître, X., Corvol, P. L., Plouin, P., Cambien, F., Pascoe, L., & Soubrier, F. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00009 · Cited by 66
The genetics of essential hypertension
O’Shaughnessy, K. M. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01254.x · Cited by 63
Liang, M., Yuan, B., Rute, E., Greene, A. S., Olivier, M., & Cowley, A. W. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00089.2002 · Cited by 64
Clinical Use of Laboratory Tests for the Identification of Secondary Forms of Arterial Hypertension
Rossi, G. P., Seccia, T. M., & Pessina, A. C. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360600931831 · Cited by 64
Lavery, G. G., Ronconi, V., Draper, N., Rabbitt, E. H., Lyons, V., Chapman, K. E., Walker, E. A., McTernan, C. L., Giacchetti, G., Mantero, F., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000083340.57063.35 · Cited by 64
Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function
Hadoke, P. W. F., Macdonald, L. J., Logie, J. J., Small, G. R., Dover, A. R., & Walker, B. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5427-2 · Cited by 63
11beta-hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells
Leckie, C., Welberg, L., & Seckl (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590233 · Cited by 55
Obeyesekere, V. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3381 · Cited by 59
Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole
Beck, K. R., Bächler, M., Vuorinen, A., Wagner, S., Akram, M., Griesser, U. J., Temml, V., Klusoňová, P., Yamaguchi, H., Schuster, D., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.010 · Cited by 62
Ferrari, P., Obeyesekere, V. R., Li, K., Wilson, R. C., New, M. I., Funder, J. W., & Krozowski, Z. S. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03787-2 · Cited by 62
Brereton, P. S., van Driel, R., Suhaimi, F. H., Koyama, K., Dilley, R., & Krozowski, Z. S. (2001) · Endocrinology · doi:10.1210/endo.142.4.8088 · Cited by 61
Genetic analysis of 22 candidate genes for hypertension in the Japanese population
Iwai, N., Tago, N., Yasui, N., Kokubo, Y., Inamoto, N., Tomoike, H., & Shioji, K. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00012 · Cited by 61
SDR-type human hydroxysteroid dehydrogenases involved in steroid hormone activation
Wu, X., Lukacik, P., Kavanagh, K. L., & Oppermann, U. C. T. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.006 · Cited by 61
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 60
The role of 11β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Uum, S. H. M. V., Hermus, A. R., Smits, P., Thien, T., & Lenders, J. W. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00299-x · Cited by 59
Ontogeny and sexual dimorphic expression of mouse type 2 11β-hydroxysteroid dehydrogenase
Condon, J. C., Ricketts, M., Whorwood, C. B., & Stewart, P. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04000-8 · Cited by 60
Koutnikova, H., Laakso, M., Lu, L., Combe, R., Paananen, J., Kuulasmaa, T., Kuusisto, J., Häring, H.-U., Hansen, T., Pedersen, O., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000591 · Cited by 58
Suzuki, T., Sasano, H., Suzuki, S., Hirasawa, G., Takeyama, J., Muramatsu, Y., Date, F., Nagura, H., & Krozowski, Z. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5227 · Cited by 53
Hatakeyama, H., Inaba, S., & Miyamori, I. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1179 · Cited by 58
Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome
Carvajal, C. A., Tapia-Castillo, A., Vecchiola, A., Baudrand, R., & Fardella, C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz315 · Cited by 59
Nikkilä, H., McMillan, D. R., Nunez, B. S., Pascoe, L., Curnow, K. M., & White, P. C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.9.0511 · Cited by 58
Self-citationCarvajal, C. A., González, A. A., Romero, D. G., González, Á., Mosso, L. M., Lagos, E., Hevia, M. D. P., Rosati, M. P., Pérez‐Acle, T., Gómez-Sánchez, C. E., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021909 · Cited by 58
Mustonen, M., POUTANEN, M. H., Kellokumpu, S., de Launoit, Y., ISOMAA, V. V., Vihko, R., & Vihko, P. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0200067 · Cited by 58
TNF‐α enhances intracellular glucocorticoid availability
Heiniger, C. D., Rochat, M. K., Frey, F. J., & Frey, B. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03004-6 · Cited by 58
Inhibition of 11β-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis
Ackermann, D., Vogt, B., Escher, G., Dick, B., Reichen, J., Frey, B. M., & Frey, F. J. (1999) · Hepatology · doi:10.1002/hep.510300303 · Cited by 51
Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9.
Liu, S., Huang, C., Li, D., Ren, W., Zhang, H., Qi, M., Li, X., & Yu, L. (2007) · Acta Biochimica Polonica · doi:10.18388/abp.2007_3289 · Cited by 52
Regulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol
Gomez-Sanchez, E. P., Ganjam, V., Chen, Y. J., Liu, Y., Zhou, M. Y., Toroslu, C., Romero, D. G., Hughson, M. D., de Rodriguez, A., & Gomez-Sanchez, C. E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2002 · Cited by 54
Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome
Moudgil, A., Rodich, G., Jordan, S. C., & Kamil, E. S. (2000) · Pediatric Nephrology · doi:10.1007/s004670000377 · Cited by 56
Quinkler, M., Oelkers, W., & Diederich, S. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440087 · Cited by 49
Genetic Analysis in Human Hypertension.
Kato, N. (2002) · Hypertension Research · doi:10.1291/hypres.25.319 · Cited by 54
Glycyrrhetinic Acid Decreases Plasma Potassium Concentrations in Patients with Anuria
Serra, A. L., Uehlinger, D. E., Ferrari, P., Dick, B., Frey, B. M., Frey, F. J., & Vogt, B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131191 · Cited by 54
Renal tubular transport and the genetic basis of hypertensive disease
Lang, F. J. W., Capasso, G., Schwab, M. G., & Waldegger, S. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0355-x · Cited by 54
Present status of genetic mechanisms in hypertension
Luft, F. C. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00118-4 · Cited by 54
Ruschitzka, F. T., Quaschning, T., Noll, G., deGottardi, A., Rossier, M. F., Enseleit, F., Hürlimann, D., Lüscher, T. F., & Shaw, S. (2001) · Circulation · doi:10.1161/01.cir.103.25.3129 · Cited by 54
Molecular genetics of salt-sensitivity and hypertension.
Luft, F. C. (2001) · PubMed · Cited by 53
Reflections on Telomeres, Growth, Aging, and Essential Hypertension
Aviv, A., & Aviv, H. (1997) · Hypertension · doi:10.1161/01.hyp.29.5.1067 · Cited by 53
Gene Targeting Approaches to Analyzing Hypertension
TAKAHASHI, N., & SMITHIES, O. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071598 · Cited by 49
Atanasov, A. G., Ignatova, I. D., Nashev, L. G., Dick, B., Ferrari, P., Frey, F. J., & Odermatt, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006111235 · Cited by 52
Metadata
- Authors
- Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature Genetics
- Published
- 1995-08-01
- Volume
- 10
- Issue
- 4
- Pages
- 394-399
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2034652601
- Semantic Scholar
- 39186032ea056bd01960beb7624e326d14d1cda1
- Cited by
- 619
- References
- 57
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 4 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 13 · 2013: 15 · 2012: 15
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk034400-10, 5r01dk042169-12)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42169, DK-34400)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- apparent mineralocorticoid excess, hypertension, 11β-hydroxysteroid dehydrogenase, genetic mutations, mineralocorticoid receptor, cortisol, aldosterone, sodium retention, genetic hypertension, kindred
- MeSH terms
- Adolescent, Adult, Base Sequence, Child, Child, Preschool, Female, Humans, Hydroxysteroid Dehydrogenases, Hypertension, Infant, Infant, Low Birth Weight, Infant, Newborn, Isoenzymes, Kidney, Male, Mineralocorticoids, Molecular Sequence Data, Mutation, Risk Factors, DNA Primers, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.